NCT00183443.
Methods | A 12‐week, double‐blind, placebo‐controlled ambulatory study |
Participants | n = 75 with bipolar I disorder with hypomanic, manic, or mixed episodes |
Interventions | Open‐label divalproex plus adjunctive blinded lithium carbonate, quetiapine or placebo |
Outcomes | Symptoms of mania, as measured by YMRS (time frame: week 12) |
Notes |
NCT00183443 (study results available January 2019) |